Investors are betting on drug companies that are developing potential treatment for the new coronavirus. But CGrantWSJ explains why that surge will probably be short lived. WSJWhatsNow
While companies affected by the novel coronavirus outbreak have watched their stock prices plunge, those with a possible solution have surged.
Shares of Vir Biotechnology, which announced an effort to develop a Covid-19 treatment on Tuesday morning, have more than doubled this week, despite a swoon on Friday. Moderna, which has delivered a potential vaccine for use in human trials, nearly doubled before retreating. The rally came as...
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wall Street snaps up drug companies offering hopes of coronavirus drug - Business InsiderInvestors have, predictably, begun placing bets on which company can produce a cure for the COVID-19 coronavirus at the root of the sell-off.
Read more »
Coronavirus live updates: FDA reports 1st drug shortage due to novel coronavirus outbreakLATEST: Two more patients who had been passengers on the Diamond Princess cruise ship have died, Japanese officials report. They are the firth and sixth passengers to die from COVID-19 after being aboard the quarantined cruise ship.
Read more »
Gilead starts two late-stage studies to test drug for coronavirusGilead Sciences Inc said on Wednesday it has started two late-stage studies to t...
Read more »
Gilead to Kick Off Its Own Studies of Potential Coronavirus DrugGilead Sciences said it would start late-stage studies of its experimental treatment for the coronavirus in March, an acceleration of its push to evaluate what it hopes could be the first medicine specifically approved to treat the respiratory disease
Read more »
Coronavirus could lead to drug shortages in USThe recent coronavirus outbreak has revealed vulnerabilities in supply chains that deliver drugs to the U.S.
Read more »
FDA reports 1st drug shortage due to novel coronavirus outbreakThe FDA announced it's been alerted to the first manufacturing shortage of an unnamed drug, due to a viral outbreak that began in China and has now reached American soil.
Read more »